Genomic characterization of clinical Enterobacterales isolates co-producing carbapenemases in Peru
Carbapenem-resistant Enterobacterales (CRE) are a growing global health threat. This project aims to genomically characterize clinical isolates co-producing carbapenemases in Peru using hybrid whole-genome sequencing (Illumina and Oxford Nanopore). The study will identify resistance genes, mobile elements, and high-risk clones to improve surveillance and control strategies.